# Phase I Single and Multiple Escalating Dose Study of RGN1016 in Healthy Male Subjects

> **NCT02820155** · PHASE1 · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** RGN1016
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02820155
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-06
- **Primary completion:** 2017-02
- **Final completion:** 2017-02
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2016-07-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02820155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02820155, "Phase I Single and Multiple Escalating Dose Study of RGN1016 in Healthy Male Subjects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02820155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*